Implants

CERIS Announces Innovations in Artificial Intelligence and Machine Learning That Improve Payment Integrity

Generative AI advances claim efficiency and accuracyFORT WORTH, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Advancements in artificial intelligence (AI)…

1 year ago

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update

 - 510(k) product clearance gained for lead product, FemaSeed potentially allowing sooner-than-expected product commercialization - - Patient enrollment has commenced…

1 year ago

Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

1 year ago

Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency

Kinaxis empowers medical technology company to get products in the hands of patients fasterOTTAWA, Ontario--(BUSINESS WIRE)--Confluent Medical, a leading materials…

1 year ago

Sientra to Present at the Stifel 2023 Healthcare Conference

IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company…

1 year ago

Establishment Labs Reports Third Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

1 year ago

Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants

In a 100-patient study of Mia there were no reports of capsular contracture or rupture. The new Zensor™ RFID platform…

1 year ago

DEXIS Announces Intraoral Scanner Software Integration with EasyRx

QUAKERTOWN, PA / ACCESSWIRE / October 12, 2023 / DEXIS, a leading innovator of dental imaging technologies, is proud to…

1 year ago

Alimera Announces Multiple Presentations Highlighting ILUVIEN® and YUTIQ® Data at Retina Society Annual Congress

ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is…

1 year ago

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

Extraordinary General Meeting called to approve the capital increase planned for January 2024 Drawdown of the first tranche of the…

1 year ago